Talis Biomedical Corp Quarterly Depreciation in USD for Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Talis Biomedical Corp annual/quarterly Depreciation history and growth rate for Q3 2022.
  • Talis Biomedical Corp Depreciation for the quarter ending September 30, 2022 was $3.3M.
  • Talis Biomedical Corp annual Depreciation for 2022 was $6.6M, a 313% increase from 2021.
  • Talis Biomedical Corp annual Depreciation for 2021 was $1.6M, a 100% increase from 2020.
Depreciation, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $3.3M Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.